Skip to main content
FinSpry Logo
FinSpry
BDTX logo
BDTX
(NASDAQ)
Black Diamond Therapeutics, Inc.
$2.39-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Black Diamond Therapeutics (BDTX) Stock Price & Financial Analysis

Black Diamond Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$2.28 - $2.49
52-Week High$4.94
52-Week Low$1.20
Open$2.29
Volume534.51K
Average Volume (3M)534.51K
Market Cap136.06M
Shares Outstanding56.93M
P/E Ratio (TTM)6.17
Price to Sales (P/S)1.89
Price to Book (P/B)1.05
EV/EBITDA9.66
Revenue (TTM)70.00M
Net Income (TTM)21.50M
EPS (TTM)$0.38
Profit Margin30.71%
Operating Margin16.94%
Return on Equity (ROE)17.04%
Debt to Equity0.13
50-Day MA$2.31
200-Day MA$2.93
52-Week Change56.38%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%

Frequently Asked Questions About Black Diamond Therapeutics

What is the current stock price for BDTX?

As of the latest trading session, BDTX stock trades at $2.39. The 52-week range is $1.20–$4.94, with a day range of $2.28–$2.49.

What is the P/E ratio for BDTX?

Black Diamond Therapeutics's trailing P/E ratio is 6.2, meaning investors pay $6.2 for every $1 of annual earnings. Black Diamond Therapeutics operates in the Healthcare sector.

Does BDTX pay dividends?

Black Diamond Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for BDTX?

Based on 2 analysts, the consensus for BDTX is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of BDTX?

Black Diamond Therapeutics's market capitalization is $136.1M, classifying it as a micro-cap company. Black Diamond Therapeutics operates in the Healthcare sector within the Biotechnology industry.